Dian Diagnostics Group Co Ltd
SZSE:300244

Watchlist Manager
Dian Diagnostics Group Co Ltd Logo
Dian Diagnostics Group Co Ltd
SZSE:300244
Watchlist
Price: 10.82 CNY -1.99% Market Closed
Market Cap: 6.8B CNY
Have any thoughts about
Dian Diagnostics Group Co Ltd?
Write Note

Gross Margin
Dian Diagnostics Group Co Ltd

27.3%
Current
34%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
27.3%
=
Gross Profit
3.4B
/
Revenue
12.4B

Gross Margin Across Competitors

Country CN
Market Cap 6.8B CNY
Gross Margin
27%
Country US
Market Cap 78.1B USD
Gross Margin
11%
Country US
Market Cap 74.5B EUR
Gross Margin
11%
Country US
Market Cap 57.6B USD
Gross Margin
14%
Country DE
Market Cap 25.5B EUR
Gross Margin
25%
Country DE
Market Cap 18.9B EUR
Gross Margin
24%
Country US
Market Cap 19.2B USD
Gross Margin
28%
Country US
Market Cap 17B USD
Gross Margin
33%
Country DE
Market Cap 12.8B EUR
Gross Margin
25%
Country US
Market Cap 12.6B USD
Gross Margin
33%
Country AU
Market Cap 13.2B AUD
Gross Margin
84%
No Stocks Found

Dian Diagnostics Group Co Ltd
Glance View

Market Cap
6.8B CNY
Industry
Health Care

Nestled in the bustling city of Hangzhou, Dian Diagnostics Group Co Ltd has carved out a pivotal role in China's healthcare landscape. Established in 1996, the company's journey began with the humble yet crucial task of providing diagnostic services. Over the years, as the wave of technological innovation swept across the globe, Dian Diagnostics harnessed its potential to expand its service offerings, evolving into a comprehensive medical diagnostics powerhouse. The company operates through its expansive network of diagnostic laboratories, which leverage cutting-edge tools to deliver precise and timely results. This network serves hospitals, clinics, and other healthcare establishments, thus forming a vital link in the healthcare delivery chain. The heart of Dian Diagnostics' business model lies in its ability to integrate advanced technological solutions with healthcare needs, ensuring scalability and efficiency. The company's revenue streams primarily flow from the provision of diagnostic testing services and sales of diagnostic equipment and reagents. Owing to its commitment to innovation, Dian Diagnostics invests heavily in research and development, continuously enhancing its offerings in molecular diagnostics, pathology, and healthcare IT solutions. By catering to the ever-growing demand for reliable and rapid diagnostic services, the company sustains its growth momentum while contributing significantly to the advancement of healthcare quality in China.

Intrinsic Value
28.78 CNY
Undervaluation 62%
Intrinsic Value
Price
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
27.3%
=
Gross Profit
3.4B
/
Revenue
12.4B
What is the Gross Margin of Dian Diagnostics Group Co Ltd?

Based on Dian Diagnostics Group Co Ltd's most recent financial statements, the company has Gross Margin of 27.3%.